Daunorubicin HCl

12,000 m2 High integrated manufacturing facility
Full Analysis capability
Thin Film Coating Lab
Contact us
Send message
Product Details

Daunorubicin HCl

Cas No.: 23541-50-6

Chemical Name:

10-[(3-Amino-2,3,6-trideoxy-indole-L-lysylpyranyl)oxy]-7,8,9,10-tetrahydro-6,8,11- Hydrochloride of trihydroxy-8-acetyl-1-methoxy-5,12-naphthalenedione (8S-10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy -ɑ-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride


Orange-red crystalline powder; hygroscopic


Shade, seal and store in a cool dry place.


Cytotoxic drug

Clinical application:

1, acute granulocyte leukemia: whether it is a single use of daunorubicin or combined with other anti-tumor drugs, daunorubicin is suitable for the treatment of the various stages of the disease. Also used to treat promyelocytic leukemia.

2, acute lymphocytic leukemia: treatment of the disease with daunorubicin, the remission rate is very high, but due to its side effects and other effective treatments, daunorubicin is only suitable for those who have developed resistance to other drugs Case of medicine. The combination of daunorubicin, prednisone and vincristine in the acute phase of acute effusion has proven to be very successful.

3, other tumors: daunorubicin has been observed to have a good effect on neuroblastoma and rhabdomyosarcoma.

If you have any suggestions or question for us,please contact us.

The content with * is required, others can be optional.

The young but global-oriented Lunan Pharmaceutical Group will achieve new, greater leap in revitalization of national medicine and creating an international century brand.
Copyright © 2022 Lunan Pharmaceutical Group All Rights Reserved.     Design By yunsu